GRIBAUDO, GIORGIO
GRIBAUDO, GIORGIO
Cranberry (Vaccinium macrocarpon) Extract Impairs Nairovirus Infection by Inhibiting the Attachment to Target Cells
2021 Mirandola, Mattia; Salvati, Maria Vittoria; Rodigari, Carola; Appelberg, K Sofia; Mirazimi, Ali; Maffei, Massimo E; Gribaudo, Giorgio; Salata, Cristiano
Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on "The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts"
2019 Mercorelli, Beatrice; Luganini, Anna; Palù, Giorgio; Gribaudo, Giorgio; Loregian, Arianna
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein
2018 Mercorelli, Beatrice; Luganini, Anna; Celegato, Marta; Palù, Giorgio; Gribaudo, Giorgio; Loregian, Arianna
Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins
2022 Maffei, Massimo E; Salata, Cristiano; Gribaudo, Giorgio
The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs
2021 Mercorelli, B.; Celegato, M.; Luganini, A.; Gribaudo, G.; Lepesheva, G. I.; Loregian, A.
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication
2020 Mercorelli, Beatrice; Luganini, Anna; Celegato, Marta; Palu', Giorgio; Gribaudo, Giorgio; Lepesheva, Galina I.; Loregian, Arianna
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity
2019 Luganini, Anna; Mercorelli, Beatrice; Messa, Lorenzo; Palù, Giorgio; Gribaudo, Giorgio; Loregian, Arianna